Emcure Pharma

Top stocks in focus on July 10: HCL Tech, Oil India, JSW Energy, Emcure Pharma, Adani Enterprises and more

Kotak Securities upgrades Emcure to ‘Buy,’ revises target price higher to ₹1,680

Kotak Securities has upgraded Emcure Pharmaceuticals to "Buy" from "Add," raising its target price to ₹1,680.

Kotak initiates Add call on Emcure Pharma, expects stock to rally 10.5% from current share price

Jefferies initiates coverage with Buy rating on Emcure Pharma, expects stock to rally 15%

Jefferies has initiated coverage on Emcure Pharma with a 'Buy' rating and set a target price of Rs 1,600 per share, indicating a 15% upside from the current market price of Rs 1,385.